Request Support
Welcome
Login NRDR Portal

DIR DR Measures

Purpose

This article describes the data elements and the clinical performance measures for the exposure and dose indices used in the DIR-DR:

  • Exposure Index (EI)

  • Target Exposure Index (EIT)

  • Deviation Index (DI)

  • Kerma-Area Product (KAP)         

They are extracted from the Radiation Dose Structure Reports. 


Note: Please refer to the DIR Data Dictionary article for a full list of DICOM and Structured Report tags we capture and report.


For the most common or higher kerma-area product exams, clinical performance measures are reported by body part and view (e.g., chest PA). For other exams, the measures are reported by ACR Common ID procedure (e.g., 4013092: RAD, chest).

 

Exposure Index (EI)

Data Element

Clinical Performance Measure

  • Exposure Index (TID 113845)

  • Study Description (0033, 1004)

  • Acquisition Protocol (TID 125203)

  • Image View (TID 111031)

  • Median, 25th, and 75th percentile values of EI distribution

 

Understanding the Measure

  • In DIR-DR, EI represents the exposure index concept defined in IEC standard 624942-1. 

  • It is an indicator of the air kerma at the image receptor, which in turn influences image noise and therefore impacts image quality.

  • EI is not a metric of patient dose or risk.

 

 

Target Exposure Index (EIT)

Data Element

Clinical Performance Measure

  • Target Exposure Index (TID 113846)

  • Study Description (0033, 1004)

  • Acquisition Protocol (TID 125203)

  • Image View (TID 111031)

  • Median, 25th, and 75th percentile values of EIT distribution 

  • EIT mode (for registry statistics only)

Understanding the Measure

  • EIT is the expected value of the EI when exposing the x-ray image receptor properly. 

  • EIT may depend on the type of image receptor, the type of examination, the diagnostic question and other factors. It can be set by the manufacturer or by the imaging facility.

  • Evaluating the appropriateness of the EIT values for various examinations is an important component of a facility’s ongoing QC program.

  • In general, adjusting EIT requires the review of clinical image quality in consultation with a radiologist. Its adjustment should not be made based on statistical results alone. For example, one may attempt to adjust EIT to match the median EI observed in the facility data. However, the median EI may simply reflects a general trend of overexposure or underexposure. Using it to set a new EIwould only serve to validate the existing suboptimal practice.

  • Currently, EIT mode is reported in the Registry Statistics by Procedure dashboard only. 


 

Deviation Index (DI)

Data Element

Clinical Performance Measure

  • Deviation Index (TID 113847)

  • Study Description (0033, 1004)

  • Acquisition Protocol (TID 125203)

  • Image View (TID 111031)

  • Median, 25th, and 75th percentile values of DI distribution 

  • Weighted DI standard deviation for a facility (Wgt DI Std)

Understanding the Measure

  • Deviation index is defined as

  • It quantifies how much the measured EI deviates from the EIT.

  • A DI of +3 indicates the EI is approximately 100% higher than intended (a doubling).

  • A DI of –3 indicates the EI is approximately 50% lower than intended (a halving).

  • When the median DI differs substantially from zero, it could be due to 

    • suboptimal EIT setting, 

    • suboptimal programmed techniques, 

    • insufficient adherence to the programmed techniques, or 

    • miscalibration of the automatic exposure control (AEC) device.

  • Because DI typically follows a normal distribution, its standard deviation serves as a measure of the extent of practice variation. 

  • Considering that an imaging facility may have multiple DR stations, a weighted DI standard deviation (Wgt DI Std) is defined for the entire facility to account for the difference in procedure volume among different DR stations: where Ni is the number of events contributed by DR station i.

    • Wgt DI Std is a measure of the degree of practice variation at the facility. Efforts to standardize techniques and practice should lead to a reduction of Wgt DI Std over time.

 

Kerma-Area Product (KAP)

Data Element

Clinical Performance Measure

  • Dose Area Product (TID 122130)

  • Study Description (0033, 1004)

  • Acquisition Protocol (TID 125203)

  • Image View (TID 111031)

  • Median, 25th, and 75th percentile values of KAP distribution

 

Understanding the Measure

  • KAP quantifies the total amount of radiation energy delivered to a patient by considering both the intensity of the radiation (kerma) and the area over which it is applied.

  • In the DIR-DR reports, it is expressed in the unit of mGy·cm².

  • It provides a measure that correlates with the overall stochastic radiation risk to the patient.

Did you find it helpful? Yes No

Send feedback
Sorry we couldn't be helpful. Help us improve this article with your feedback.